Sapphiros AI Bio LLC announced that it has raised $30 million in a round of funding led by new investor, OraSure Technologies, Inc. on January 4, 2024. The company issued common shares in the transaction. As a part of transaction, the investor became the part of board of the company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.215 USD | -0.12% |
|
-7.38% | -48.72% |
06-24 | OraSure Technologies, Inc.(NasdaqGS:OSUR) dropped from S&P 600 Health Care | CI |
06-24 | OraSure Technologies, Inc.(NasdaqGS:OSUR) dropped from S&P 1000 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.72% | 312M | |
-4.91% | 184B | |
-3.41% | 103B | |
-4.79% | 67.59B | |
+15.41% | 46.93B | |
-9.85% | 43.87B | |
+8.28% | 41.2B | |
+16.79% | 30.47B | |
+13.59% | 24.16B | |
-7.76% | 23.57B |
- Stock Market
- Equities
- OSUR Stock
- News OraSure Technologies, Inc.
- Sapphiros AI Bio LLC announced that it has received $30 million in funding from OraSure Technologies, Inc.